The WHO defines luminal A breast cancer as hormone receptor (HR) positive, HER2 negative, with Ki-67 less than 14% and PR greater than 20%, while luminal B is defined as estrogen receptor (ER) positive, HER2 negative, with Ki-67 greater than 14% or PR less than 20%. The gene discussed is ERBB2; the disease is breast cancer.